Cardiovascular risk

Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients.
[19432982] BMC Cardiovasc Disord 9(-): 17 (2009)

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
[18048761] Pharmacol Rev 59(4): 418-58 (2007)

Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.
[19355805] Am J Manag Care 15(3 Suppl): S65-73 (2009)

Conditional risk factors for atherosclerosis.
[15704777] Mayo Clin Proc 80(2): 219-30 (2005)

Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.
[18990318] Mayo Clin Proc 83(11): 1203-12 (2008)

Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
[17285783] Mayo Clin Proc 82(1): 29-39 (2007)

Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review.
[19884567] Hypertension 54(6): 1328-36 (2009)

PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry.
[20479152] Circulation 121(21): 2284-93 (2010)

Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.
[19255343] Circulation 119(10): 1363-9 (2009)

American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention.
[18833586] Circulation 118(14): 1497-1518 (2008)

Leptin and cardiovascular disease: response to therapeutic interventions.
[18574061] Circulation 117(25): 3238-49 (2008)

The ankle-brachial index as a biomarker of cardiovascular risk: it's not just about the legs.
[19901185] Circulation 120(21): 2033-5 (2009)

Chronic inflammation links cardiovascular, metabolic and renal diseases.
[22067929] Circ J 75(12): 2739-48 (2011)

Role of adiponectin in cardiovascular protection.
[20145339] Circ J 74(3): 432-3 (2010)

Obesity-related risk factors of cardiovascular disease.
[19940368] Circ J 73(12): 2204-5 (2009)

Adiponectin and cardiovascular disease.
[19261992] Circ J 73(4): 608-14 (2009)

Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans.
[15591226] Arterioscler Thromb Vasc Biol 25(2): 279-86 (2005)

Endothelial dysfunction: a marker of atherosclerotic risk.
[12588755] Arterioscler Thromb Vasc Biol 23(2): 168-75 (2003)

Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.
[18716322] Arterioscler Thromb Vasc Biol 28(9): 1582-3 (2008)

Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review.
[15879302] Arterioscler Thromb Vasc Biol 25(7): 1463-9 (2005)

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).
[17726041] Eur Heart J 28(19): 2375-414 (2007)

New cardiovascular risk factors exist, but are they clinically useful?
[18276617] Eur Heart J 29(4): 441-4 (2008)

New cardiovascular risk determinants do exist and are clinically useful.
[18276616] Eur Heart J 29(4): 436-40 (2008)

Pregnancy-associated plasma protein-A and cardiovascular risk.
[16790470] Eur Heart J 27(14): 1637-9 (2006)

Where vascular meets neurodegenerative disease.
[20876491] Stroke 41(10 Suppl): S144-6 (2010)

Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review.
[14576382] Stroke 34(11): 2741-8 (2003)

Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease.
[14593126] Stroke 34(11): 2583-90 (2003)

Advances in population-based studies.
[20075344] Stroke 41(2): e99-101 (2010)

Statin therapy for stroke prevention.
[18258828] Stroke 39(3): 1042-8 (2008)

A systematic review of angiotensin receptor blockers in preventing stroke.
[19892999] Stroke 40(12): 3876-8 (2009)

Clinical impact of evaluation of cardiovascular control by novel methods of heart rate dynamics.
[19324705] Philos Transact A Math Phys Eng Sci 367(1892): 1223-38 (2009)

Endocrine aspects of obstructive sleep apnea.
[20061419] J Clin Endocrinol Metab 95(2): 483-95 (2010)

Aldosterone as a cardiovascular risk hormone.
[17409575] Endocr J 54(3): 359-70 (2007)

Molecular determinants of the cardiometabolic phenotype.
[20384572] Endocr Metab Immune Disord Drug Targets 10(2): 109-23 (2010)

Glucocorticoids and cardiovascular disease.
[17984234] Eur J Endocrinol 157(5): 545-59 (2007)

Mortality in patients with pituitary disease.
[20086217] Endocr Rev 31(3): 301-42 (2010)

Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Porphyromonas gingivalis is the important role of intimal hyperplasia in the aorta.
[20501963] J Pharmacol Sci 113(2): 110-4 (2010)

Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Cell-surface structures of novel serotype k Streptococcus mutans strains and their correlation to virulence.
[20501965] J Pharmacol Sci 113(2): 120-5 (2010)

Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Implication of periodontal diseases in development of systemic diseases.
[20501966] J Pharmacol Sci 113(2): 103-9 (2010)

Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Involvement of Porphyromonas gingivalis in the development of human aortic aneurysm.
[20501967] J Pharmacol Sci 113(2): 115-9 (2010)

Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis.
[22039429] PLoS One 6(10): e25920 (2011)

A two-carbon switch to sterol-induced autophagic death.
[17172803] Autophagy 3(1): 38-41 (2007)

Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications.
[15229146] Clin Chem 50(7): 1113-5 (2004)

Neopterin and cardiovascular disease: growing evidence for a role in patient risk stratification.
[19395434] Clin Chem 55(6): 1056-7 (2009)

Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?
[19556446] Clin Chem 55(8): 1462-70 (2009)

Cystatin C and cardiovascular risk.
[19713275] Clin Chem 55(11): 1932-43 (2009)

Radiation as a risk factor for cardiovascular disease.
[21091078] Antioxid Redox Signal 15(7): 1945-56 (2011)

Endothelial dysfunction: a crystal ball prediction for enhanced cardiovascular risk?
[14719473] Isr Med Assoc J 5(10): 736-8 (2003)

Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more.
[17975198] Am J Respir Crit Care Med 177(4): 369-75 (2008)

Bacteremia originating in the oral cavity. A review.
[18521055] Med Oral Patol Oral Cir Bucal 13(6): E355-62 (2008)

Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
[20032323] N Engl J Med 361(26): 2518-28 (2009)

Clinical usefulness of plasma homocysteine in vascular disease.
[15377241] Med J Aust 181(6): 314-8 (2004)

Preventing vascular disease - effective strategies for implementing guidelines in general practice.
[22003490] Aust Fam Physician 40(10): 825-8 (2011)

Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.
[19622820] JAMA 302(4): 412-23 (2009)

Erectile dysfunction: a marker of early coronary heart disease.
[17715608] Hellenic J Cardiol 48(4): 185-91 (2007)

Overestimation and underestimation of cardiovascular risk in clinical practice: usefulness of risk estimation charts.
[18196656] Hellenic J Cardiol 48(6): 341-5 (2007)

Erectile dysfunction and coronary artery disease: a relationship for disclosure.
[18350775] Hellenic J Cardiol 49(1): 1-6 (2008)

Cardiovascular consequences of obstructive sleep apnoea.
[20308745] Indian J Med Res 131(-): 196-205 (2010)

Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation.
[19407053] Eur Respir J 33(5): 1195-205 (2009)

Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels.
[17583180] Vasc Health Risk Manag 3(1): 99-108 (2007)

Measurement of endothelial function and its clinical utility for cardiovascular risk.
[18827914] Vasc Health Risk Manag 4(3): 647-52 (2008)

Periodontal bacteria and cardiovascular problems.
[19492958] Future Microbiol 4(5): 495-8 (2009)

Altered central catecholaminergic transmission and cardiovascular disease.
[18326552] Exp Physiol 93(6): 725-40 (2008)

Apo B/apo A-I ratio and cardiovascular risk prediction.
[17664987] Arq Bras Cardiol 88(6): e187-90 (2007)

Risk factors for the development of atherosclerosis in childhood and adolescence.
[18516390] Arq Bras Cardiol 90(4): 276-283 (2008)

Role of vitamin D in cardiovascular disease.
[20308705] Neth J Med 68(3): 113-8 (2010)

Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions.
[21941583] Clin Dev Immunol 2012(-): 974648 (2012)

The dark side of testosterone deficiency: III. Cardiovascular disease.
[19342698] J Androl 30(5): 477-94 (2009)

Far-infrared saunas for treatment of cardiovascular risk factors: summary of published evidence.
[19602651] Can Fam Physician 55(7): 691-6 (2009)

Vascular consequences of dietary salt intake.
[19339634] Am J Physiol Renal Physiol 297(2): F237-43 (2009)

Cardiovascular disease in transplant recipients: current and future treatment strategies.
[18309001] Clin J Am Soc Nephrol 3 Suppl 2(-): S29-37 (2008)

Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?
[18184879] Clin J Am Soc Nephrol 3(2): 505-21 (2008)

Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly.
[21472089] Clin Interv Aging 6(-): 27-35 (2011)

New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor.
[18686755] Clin Interv Aging 3(2): 341-9 (2008)

Vascular biomarkers in the metabolic syndrome.
[19379078] Expert Rev Mol Diagn 9(3): 209-15 (2009)

Endothelial dysfunction as a target for prevention of cardiovascular disease.
[19875572] Diabetes Care 32 Suppl 2(-): S314-21 (2009)

Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: a systematic review of the literature.
[20200624] Tex Heart Inst J 37(1): 25-39 (2010)

The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases.
[18408140] Exp Biol Med (Maywood) 233(6): 674-88 (2008)

Tailor-made therapy for the prevention of acute coronary syndromes: future role of biomarkers in risk stratification and disease management.
[18402533] Expert Rev Cardiovasc Ther 6(4): 435-7 (2008)

Type D personality: the heart, stress, and cortisol.
[15820973] QJM 98(5): 323-9 (2005)

Adipokines--targeting a root cause of cardiometabolic risk.
[18550581] QJM 101(10): 767-76 (2008)

Periodontal disease as a risk marker in coronary heart disease and chronic kidney disease.
[20948377] Curr Opin Nephrol Hypertens 19(6): 519-26 (2010)

Mechanisms for increased cardiovascular disease in chronic kidney dysfunction.
[19374004] Curr Opin Nephrol Hypertens 18(3): 181-8 (2009)

Molecular mechanisms in exercise-induced cardioprotection.
[21403846] Cardiol Res Pract 2011(): 972807 (2011)

1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus.
[19667238] Circulation 120(8): 687-98 (2009)

New techniques for assessing arterial stiffness.
[18358423] Diabetes Metab 34 Suppl 1(-): S21-6 (2008)

Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.
[20445552] J Invest Dermatol 130(7): 1785-96 (2010)

The endocannabinoid system: potential for reducing cardiometabolic risk.
[19373218] Obesity (Silver Spring) 17(10): 1821-9 (2009)

A new Web-based medical tool for assessment and prevention of comprehensive cardiovascular risk.
[21445280] Ther Clin Risk Manag 7(-): 59-68 (2011)

Risk assessment for sudden cardiac death in dialysis patients.
[20959609] Circ Arrhythm Electrophysiol 3(5): 553-9 (2010)

Role of cardiovascular imaging in systemic autoimmune diseases.
[21160590] World J Cardiol 2(8): 237-42 (2010)

Increased heart rate and atherosclerosis: potential implications of ivabradine therapy.
[21526046] World J Cardiol 3(4): 101-4 (2011)

Childhood and adolescent obesity and adult mortality: a systematic review of cohort studies.
[18797731] Cad Saude Publica 24 Suppl 4(-): s558-68 (2008)

Cardioprotection by adiponectin.
[16781946] Trends Cardiovasc Med 16(5): 141-6 (2006)

Magnesium in chronic kidney disease: challenges and opportunities.
[20090315] Blood Purif 29(3): 280-92 (2010)

Gamma-glutamyltransferase to determine cardiovascular risk: shifting the paradigm forward.
[21041983] J Atheroscler Thromb 18(3): 177-81 (2011)

Adipose tissue, inflammation and cardiovascular disease.
[20339797] Rev Assoc Med Bras 56(1): 116-21 (2010)

Cardiovascular risk during hormonal treatment in patients with prostate cancer.
[21448299] Cancer Manag Res 3(-): 49-55 (2011)

The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review.
[18199282] Int J Clin Pract 62(2): 338-51 (2008)

Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.
[20111659] Rev Obstet Gynecol 2(4): 232-9 (2009)

Obesity: effects on cardiovascular disease and its diagnosis.
[18988724] J Am Board Fam Med 21(6): 562-8 (2008)

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.
[21067804] Lancet 376(9753): 1670-81 (2010)

Microvascular responses to cardiovascular risk factors.
[20374483] Microcirculation 17(3): 192-205 (2010)

Metabolic consequences of intermittent hypoxia: relevance to obstructive sleep apnea.
[21112030] Best Pract Res Clin Endocrinol Metab 24(5): 843-51 (2010)

Role of sleep duration in the regulation of glucose metabolism and appetite.
[21112019] Best Pract Res Clin Endocrinol Metab 24(5): 687-702 (2010)

Obstructive sleep apnea: role in the risk and severity of diabetes.
[21112020] Best Pract Res Clin Endocrinol Metab 24(5): 703-15 (2010)

Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence.
[21112022] Best Pract Res Clin Endocrinol Metab 24(5): 731-43 (2010)

Evidence relating dietary sodium to cardiovascular disease.
[16772637] J Am Coll Nutr 25(3 Suppl): 256S-261S (2006)

Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival.
[16772636] J Am Coll Nutr 25(3 Suppl): 247S-255S (2006)

The influence of dietary sodium on blood pressure.
[16772635] J Am Coll Nutr 25(3 Suppl): 240S-246S (2006)

Dietary sodium intake and its relation to human health: a summary of the evidence.
[16766773] J Am Coll Nutr 25(3): 165-9 (2006)

Approach to dyslipidemia, lipodystrophy, and cardiovascular risk in patients with HIV infection.
[21181310] Curr Atheroscler Rep 13(1): 51-6 (2011)

Early identification of cardiovascular risk using genomics and proteomics.
[20440292] Nat Rev Cardiol 7(6): 309-17 (2010)

The role of Homocysteine as a predictor for coronary heart disease.
[21289945] GMS Health Technol Assess 3(-): Doc11 (2007)

Potential role of uric Acid as a risk factor for cardiovascular disease.
[20195398] Korean J Intern Med 25(1): 18-20 (2010)

Obstructive sleep apnea: the new cardiovascular disease. Part I: Obstructive sleep apnea and the pathogenesis of vascular disease.
[18807180] Heart Fail Rev 14(3): 143-53 (2009)

OSA: the new cardiovascular disease: part II: Overview of cardiovascular diseases associated with obstructive sleep apnea.
[18758946] Heart Fail Rev 14(3): 155-64 (2009)

The use of high-sensitivity assays for C-reactive protein in clinical practice.
[18711404] Nat Clin Pract Cardiovasc Med 5(10): 621-35 (2008)

Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: a systematic review and meta-analysis.
[21453547] Cardiovasc Diabetol 10(-): 25 (2011)

The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients.
[17681710] J Vasc Surg 46(3): 500-6 (2007)

Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the Heart and Soul study.
[20551373] Circ Cardiovasc Qual Outcomes 3(4): 406-12 (2010)

Epidemiologic review of long-term, low-level exposure to environmental chemicals and cardiovascular disease: an exposure-response relationship.
[21358127] Nihon Eiseigaku Zasshi 66(1): 13-21 (2011)

Principles and practice of nonpharmacological interventions to reduce cardiometabolic risk.
[20357497] Med Princ Pract 19(3): 167-75 (2010)

Interleukin-6 and cardiovascular diseases.
[15090695] Jpn Heart J 45(2): 183-93 (2004)

Migraine and cardiovascular disease: possible mechanisms of interaction.
[19470970] Neurology 72(21): 1864-71 (2009)

Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment.
[15184688] Psychosom Med 66(3): 305-15 (2004)

Peripheral blood gene expression profiling for cardiovascular disease assessment.
[18923935] Genomic Med 1(3-4): 105-12 (2007)

Metabolic and cardiovascular effects of ghrelin.
[20798901] Int J Pept 2010(-): - (2010)

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
[21098428] Circulation 122(25): e584-636 (2010)

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
[21098427] Circulation 122(25): 2748-64 (2010)

Cardiovascular disease and the role of oral bacteria.
[21523220] J Oral Microbiol 2(): (2010)

Porphyromonas gingivalis-dendritic cell interactions: consequences for coronary artery disease.
[21523219] J Oral Microbiol 2(): (2010)

Effect of water hardness on cardiovascular mortality: an ecological time series approach.
[20031964] J Public Health (Oxf) 32(4): 479-87 (2010)

The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.
[20923854] Eur J Heart Fail 12(12): 1274-81 (2010)

Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.
[24243630] J Clin Endocrinol Metab 99(1):E45-52 (2014)

Body adiposity index and all-cause and cardiovascular disease mortality in men.
[23512375] Obesity (Silver Spring) 21(9):1870-6 (2013)

Cocoa polyphenols and inflammatory markers of cardiovascular disease.
[24566441] Nutrients 6(2):844-80 (2014)

Omega-3 index and cardiovascular health.
[24566438] Nutrients 6(2):799-814 (2014)

C-reactive protein: clinical and epidemiological perspectives.
[24653858] Cardiol Res Pract 2014():605810 (2014)

Toward new biomarkers of cardiometabolic diseases.
[23770128] Cell Metab 18(1):43-50 (2013)

Genetic insights into cardiometabolic risk factors.
[24659834] Clin Biochem Rev 35(1):15-36 (2014)

Therapy of obese patients with cardiovascular disease.
[23332347] Curr Opin Pharmacol 13(2):200-4 (2013)

Genetic profiling for risk reduction in human cardiovascular disease.
[24705294] Genes (Basel) 5(1):214-34 (2014)

The role of Notch pathway in cardiovascular diseases.
[24749110] Glob Cardiol Sci Pract 2013(4):364-71 (2013)

Association between Serum Iron and the Severity of Coronary Artery Disease.
[24757630] Int Cardiovasc Res J 7(3):95-8 (2013)

Association between single nucleotide polymorphism rs1044925 and the risk of coronary artery disease and ischemic stroke.
[24577316] Int J Mol Sci 15(3):3546-59 (2014)

Apo B/Apo A-I Ratio is Statistically A Better Predictor of Cardiovascular Disease (CVD) than Conventional Lipid Profile: A Study from Kathmandu Valley, Nepal.
[24701475] J Clin Diagn Res 8(2):34-6 (2014)

Slow yogic breathing through right and left nostril influences sympathovagal balance, heart rate variability, and cardiovascular risks in young adults.
[24741554] N Am J Med Sci 6(3):145-51 (2014)

Neanderthal ancestry drives evolution of lipid catabolism in contemporary Europeans.
[24690587] Nat Commun 5():3584 (2014)

Identification of apolipoprotein D as a cardioprotective gene using a mouse model of lethal atherosclerotic coronary artery disease.
[24082102] Proc Natl Acad Sci U S A 110(42):17023-8 (2013)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Cardiovascular risk.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Cardiovascular risk.php on line 92